The managed care environment dictates that patients be diagnosed quick
ly and efficiently. In many cases, the use of point-of-care (POC) immu
noassays helps meet this requirement. Rapid immunoassays performed at
the point of care allow test results to be integrated into the decisio
n-making algorithm and contributes to prompt and appropriate treatment
; Tens of millions of rapid immunoassays are performed each year in cl
inics, physician offices, and emergency rooms throughout the United St
ates. This overview discusses the evolution of POC immunoassay technol
ogy and the state of the art for these products. Also Presented are pa
tient management scenarios in which available rapid immunoassays play
a role. This article is the first in a four-part continuing education
update series on chemistry. Other articles focus on immunosensors, imm
unoassays, and prostate-specific antigen.